Indraprastha Medical Corporation Limited

NSE:INDRAMEDCO.NS

456.15 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 12,44710,986.78,621.45,960.427,966.947,600.227,202.7437,290.9087,325.0126,934.5736,600.2895,912.3475,029.684,354.7134,244.2683,911.8533,147.0732,327.135
Cost of Revenue 8,306.74,741.63,832.42,488.633,5243,425.173,300.9823,416.6793,449.4483,342.2073,250.7223,012.0481,198.4961,079.2621,148.7121,166.949948.221669.09
Gross Profit 4,140.36,245.14,7893,471.794,442.944,175.053,901.7613,874.2283,875.5643,592.3663,349.5682,900.2993,831.1843,275.453,095.5562,744.9032,198.8531,658.045
Gross Profit Ratio 0.3330.5680.5550.5820.5580.5490.5420.5310.5290.5180.5070.4910.7620.7520.7290.7020.6990.712
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 096.968.656.579.5765.7688.59990.69189.2841,891.99280.11374.6372,172.7822,841.9412,519.1122,275.1991,850.6311,469.192
Selling & Marketing Expenses 0889.8533.5264.37489.62433.97387.632386.691381.644363.196334.147260.572000000
SG&A 2,607.5986.7602.1320.87569.19499.73476.231477.381470.9281,891.992414.26335.2092,172.7822,841.9412,519.1122,275.1991,850.6311,469.192
Other Expenses 168.9100.331.26.783,329.393,150.838.08412.74518.2439.744,631.8024,109.8821,199.62153.02972.37439.69827.234-74.572
Operating Expenses 2,607.55,130.83,937.73,395.23,898.583,650.563,474.8423,386.0633,353.1383,025.5622,707.6432,358.0353,372.4042,788.5322,591.4872,314.8961,877.8651,394.62
Operating Income 1,532.81,123851.376.6544.36524.49426.9193,947.142496.853576.544633.628534.864458.781486.919504.07430.007320.988263.426
Operating Income Ratio 0.1230.1020.0990.0130.0680.0690.0590.5410.0680.0830.0960.090.0910.1120.1190.110.1020.113
Total Other Income Expenses Net 128.348.8-60.6-33.7-62.44-78.28-86.867-3,538.966-51.948-81.071-92.088-80.052-58.571-34.236-38.542-57.475-62.751-33.708
Income Before Tax 1,661.11,171.8790.742.89481.92446.21340.052408.176444.905495.473541.54454.811400.21452.683465.527372.532258.237229.718
Income Before Tax Ratio 0.1330.1070.0920.0070.060.0590.0470.0560.0610.0710.0820.0770.080.1040.110.0950.0820.099
Income Tax Expense 421.5310.3204.519.645.68162.08129.019145.723162.561170.561187.181167.162130.25145.434154.927133.66296.75882.483
Net Income 1,239.6861.5586.223.3436.24284.13211.033262.453282.344324.912354.358287.649269.961307.249310.601238.87161.479147.235
Net Income Ratio 0.10.0780.0680.0040.0550.0370.0290.0360.0390.0470.0540.0490.0540.0710.0730.0610.0510.063
EPS 13.529.46.390.254.763.12.32.862.673.543.873.142.943.353.392.611.761.61
EPS Diluted 13.529.46.390.254.763.12.32.862.673.543.873.142.943.353.392.611.761.61
EBITDA 1,933.61,607.31,197.9383.28833.06788716.59777.184779.205858.303904.913785.904677.054712.344696.974616.685482.699399.04
EBITDA Ratio 0.1550.1460.1390.0640.1050.1040.0990.1070.1060.1240.1370.1330.1350.1640.1640.1580.1530.171